chrisvoncsefalvay/vaers-outcomes huggingface dataset:
passed out and fell; Peripheral Diabetic Neuropathy; upper back pain the radiated from side to side; spasm; numbness in hands and feet; numbness in hands and feet; passed out and fell; dizzy; legs began to tingle; lost my ability to swallow correctly; weak; had no gag reflex and couldn't cough; blow my nose; My legs hurt; had no gag reflex and couldn't cough,; This is a spontaneous report from contactable consumer (Patient herself). A 63-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: EN6198; Expiration date: unknown) via an unspecified route of administration, administered in Arm Left on 21Feb2021 11:30 as single dose for COVID-19 immunization. Medical history included diabetes mellitus, lupus-like syndrome, atrial, guillain-barre syndrome, food allergy, contrast media allergy from an unknown date and unknown if ongoing. Concomitant medications included metformin (METFORMIN), metoprolol tartrate (METOPROLOL TARTRATE), fenofibrate (FENOFIBRATE) taken for an unspecified indication. The patient previously took penicilin g, potassium, chantix and experienced hypersensitivity. Prior to vaccination, the patient was not diagnosed with COVID-19. On 22Feb2021 11:00 it was reported that, 24 hours after vaccination she started having upper back pain the radiated from side to side. 3 days later she saw PCP who ordered chest x-ray and prescribed muscle relaxer. 4th day pain was worse at night and went to ER, given different medication for spasm. 5th day, pain continued to get worse at night and went to ER had CT of abdomen/Pelvis and given different medication for spasm. 6th day pain worse, returned to ER, had back pain, numbness in hands and feet. Diagnosed with Peripheral Diabetic Neuropathy, given Gabapentin. All this time she had been running on 2 hours a sleep a day. On 10th day, she passed out and fell. On 11th day, she was dizzy and legs began to tingle so went to ER, where she was admitted over the weekend. A CT of Brain and Spine and Doppler were done. Discharged with same diagnosis. Saw Neurologist 6 weeks after onset. During this ordeal on an unspecified dates she lost her ability to swallow correctly and had no gag reflex and couldn't cough, blow her nose. Her legs hurt and she was weak. Diagnosed with GBS. The patient was hospitalized for upper back pain the radiated from side to side, spasm, numbness in hands and feet, numbness in hands and feet for 3 days. Therapeutic measures were taken as a result of weak, upper back pain the radiated from side to side, spasm, numbness in hands and feet, numbness in hands and feet, peripheral diabetic neuropathy, passed out and fell, passed out and fell, dizzy, legs began to tingle, lost my ability to swallow correctly as patient had received pain medication and physical therapy evaluation. Since the vaccination, the patient was not tested for COVID-19. The outcome of all events was not recovered.  Follow-up actions are needed. Further information has been requested.
He is asking if its okay for him to take Oxycontin for his back pain.; This is a spontaneous report received from a non-contactable consumer (patient) via Pfizer. A male patient of an unspecified age received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection; Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date after the vaccination, the patient experienced back pain. Patient enquired whether if its okay for him to take Oxycontin for his back pain. The outcome of the event was unknown.  No follow-up attempts are possible; information about batch/ lot number cannot be obtained.
Patient reported chest pain (CP); 7 days after dose 1 of Pfizer Vaccine and developed diverse rash on trunk and extremities with itching.; 7 days after dose 1 of Pfizer Vaccine and developed diverse rash on trunk and extremities with itching.; This is a spontaneous report from a contactable pharmacist. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular on 04May2021 (Batch/Lot number was not reported) as 1ST DOSE, SINGLE for covid-19 immunisation. Medical history included food allergy (chicken) from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. There was no other vaccine in four weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination and it was unknown if the patient has been tested for COVID-19 since vaccination. It was reported that on 11May2021 the patient experienced chest pain (CP), no shortness of breath and no radiation of pain approx. 7 days after dose 1 of the Vaccine and developed diverse rash on trunk and extremities with itching. No history of chest pain or GERD and takes no routine prescription medications. Treatment received includes: Antihistamine and Inhaled Corticosteroid. Events was considered serious. The outcome of the events was recovering.   Information on the lot/batch number has been requested.
Headache, myalgia, subjective fever and chills, nasal congestion and dizziness treated with OTC Tylenol Sinus, Dayquil. Seen in ER on 2/1/03 and treated with Motrin and nasal decongestant.
Pain, fever, vomiting, pain day after vaccination. Pain continuing months after vaccination. Termed "chronic pain" per pediatrician, "chronic pain due to autonomic nervous system dysfunction" per rheumatologist. Requires ongoing physical therapy and prescription medication. Currenlty awaiting neuro consult.
Muscle aches in legs and arms; tiredness and sleepiness; deep sleep lasting approx 4 hours
Patient fainted when standing for count.  Fell to the floor, lost consciousness,  and hit his head against the wall.  Reported overnight he experienced chills and lightheadedness
Patient was given dose frome expired vial; Dose administered to 26 patients from 5 vials stored in the fridge for more than 30 days; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was given dose frome expired vial) and PRODUCT STORAGE ERROR (Dose administered to 26 patients from 5 vials stored in the fridge for more than 30 days) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033H21A) for COVID-19 vaccination.     Concurrent medical conditions included HIV infection (under treatment for this illness.).   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Jan-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was given dose frome expired vial) and PRODUCT STORAGE ERROR (Dose administered to 26 patients from 5 vials stored in the fridge for more than 30 days). On 28-Jan-2022, EXPIRED PRODUCT ADMINISTERED (Patient was given dose frome expired vial) and PRODUCT STORAGE ERROR (Dose administered to 26 patients from 5 vials stored in the fridge for more than 30 days) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided. No treatment medication were provided.   This case was linked to MOD-2022-476392 (Patient Link).
Large red, itchy, rash area encircling the injection site.  Headache and general malaise.
Information has been received from a consumer concerning her son with no pertinent medical history and penicillin allergy, who on an unspecified date was vaccinated with a single dose of MMR II. The consumer mentioned that her son received all the vaccines required for his age and in approximately 2001 at age two and a half his development was not normal. He was diagnosed with autism. The consumer was not sure if the MMR II had triggered the autism but believed that receiving so many vaccines when the baby was young had a negative effect on the development. At the time of reporting, the patient's autism persisted. Upon internal review, autism was considered to be an other important medical event. No further information is available.
Extreme chronic fatigue:9 or more hours of sleep at night. on days off, after being aways for about 5hrs, I end up taking a 3-4hr nap, then go to bed at usual time of 11pm. Still extremely tired when waking up, and have no energy to do anything during the day. Seems to be increasing worse. My doctor prescribed me Adderall to help me get through work.  Intense Brain Fog: I used to have perfectly clear thought function. Now I struggle trying to remember what I was going to do, what I need to do, trying to get my thoughts out when speaking. At work, I have a hard time gathering my thoughts & what I'm trying to say when answering questions. Making obviously stupid mistakes, that I normally would never make beforehand.  Menstrual Cycles: I've been on the same birth control & take religiously for 10yrs now and my cycle ran like clockwork. Now, I begin spotting half way through my cycle for about 5 days. Then when I do have my period, it is basically nonexistent. No real bleeding, more like black in color discharge & what seems like chunks, instead of normal red blood.
Patient had CVA 9 days after booster vaccine,  patient has speech, mobility, and independence affected. Patient was independent and otherwise healthy prior to episode.
Went to doctor for shoulder pain that started prior to vaccine.  During doctors visit (12 days after 1st vaccine), an MRI was done.  The results showed multiple large benign-appearing axillary lymph nodes with the largest being 3.2 cm ( on the same side the vaccination was given 12 days prior).  Patient says she had no knowledge of these enlarged nodes and felt no symptoms created by them.
Information has been received from a office manager concerning a 22 or 23 year old female who on 20-MAR-2008 was vaccinated with a first dose of GARDASIL vaccine (yeast) (route and administration site not reported). Subsequently the patient developed white blinking light syndrome which was confirmed by an ophthalmologist. On an unspecified date recently the patient was vaccinated with a second dose of GARDASIL vaccine (yeast). The patient's outcome was unknown. The patient was to follow up with the ophthalmologist. Additional information has been requested.
received only the diluent component of SHINGRIX; received only the diluent component of SHINGRIX; This case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a patient who received Herpes zoster (Shingrix) (batch number ZJ432, expiry date 27th May 2022) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional details were provided as the age at vaccination was not reported. The patient received only the diluent component of Shingrix, which led to inappropriate dose of vaccine administered and inappropriate preparation of medication. The vaccine was given by different nurses from the facility. The health care professional had not identified which were the patients who received only the diluent component of Shingrix at the time of the reporting. No further details were provided. The reporter consented to follow up by email since the reporting nurse was not always at her desk. This case is one of 7 cases reported by same reporter. Sender's Comments:  US-GLAXOSMITHKLINE-US2019103287: same reporter US-GLAXOSMITHKLINE-US2021AMR199621: Original Case : US2021199083 US-GLAXOSMITHKLINE-US2021AMR199620:Original Case : US2021199083 US-GLAXOSMITHKLINE-US2021AMR199619:Original Case : US2021199083 US-GLAXOSMITHKLINE-US2021AMR199618:Original Case : US2021199083 US-GLAXOSMITHKLINE-US2021AMR199617:Original Case : US2021199083 US-GLAXOSMITHKLINE-US2021AMR199616:Original Case : US2021199083
Runny nose, fever, measles/rubella rash over entire body, mumps-swollen neck amd armpit.  Neck is still swollen as of 9-17-19
Swelling on opposite side, resulted in spreading of infection. Had to get the expander removed.
This case was reported by a consumer via call center representative and described the occurrence of chills in a adult female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a week after receiving SHINGRIX, the patient experienced chills and headache. On an unknown date, the outcome of the chills and headache were recovering/resolving. It was unknown if the reporter considered the chills and headache to be related to SHINGRIX. Additional case details were provided as follows: The age at vaccination was not reported. The patient did not wish to provide any demographics details. The patient received the dose of SHINGRIX approximately 6 months before the date of reporting and experienced every side effect listed in the Product Insert. The only events mentioned other than that generalized statement were chills, and headache. The patient reports that all events began to improve in about 3 days after the injection. The patient did not wish to specify her experience. The patient did not give the consent for follow up.
This spontaneous report has been received from a nurse referring to a patient of unknown age and gender. Information about concurrent condition, concomitant medication and medical history was not provided. On 17-AUG-2017, the patient was vaccinated with an expired dose of M-M-R II (route was not reported), lot # L029266 with expiration date 04-AUG-2017, reconstituted with sterile diluent (lot# L022773 with expiration date 08-MAR-2018) for prophylaxis. No adverse effects were reported.
This was not an adverse reaction. BEXSERO vaccination was given instead of PREVNAR 13. Mom advised to watch for fever, local reaction. If occurs call office.
Within a minute of receiving the vaccination, my throat and tongue began to swell.  After about 10-15 minutes, my face and head began itching and my Eustacian tubes began to close (as if flying in an airplane and unable to "pop" my ears).  I took a 25 mg benadryl right after receiving the vaccination and remained at the pharmacy for an hour observation.  When I arrived home, about 1 hour and 15 minutes after receiving the vaccination, I took another benadryl and slept for about 6 hours.  Upon waking, all symptoms were gone.  The reaction to the second vaccination was more intense than the reaction to the first Covid-19 vaccination.
Unsure if related to vaccines. Mother reports fever, being more tired than usual and 3 or 4 episodes of diarrhea on 10/16/01. Dad checked on infant in evening and found him not breathing and noticed blood from mouth. Mother was at work. Infant was alone in parents bed. COD as per autopsy report: Lymphoplasmacytic Meningitis.
pt recvd vax & did not devel a titer p/8wks;MD reported approx 14 patients;pts assigned WAES95081597 & 95081815 through 95081827
Covid arm - big red hot swollen bump below and to the left of my injection site. Tender to the touch. About 2.5 inches in diameter
Approx 5 min after injection patient c/o feeling like she was lightheaded, dizzy, coloring turning grey and was hypotensive, approx 5 min later Patient reported hand cramping, tingling in fingers and hands. During this time patient reported worsening hand cramping and stiffness.  Hands in stiff fist and unable to open hands at this time. Patient reported abdominal cramping and tightness in abdomen. Pt was given 50mg IM benadryl. approx 10 min later patient reported some improvement of symptoms, 20 min later  Patient reports able to move hands fully and tightness in abdomen gone.  Hands continue to feel tingly/shakey but overall feeling much better. Attempt to sit up, feeling very dizzy and lightheaded, patient to lie back down. 10 min later feeling better, another attempt to sit up, continues to feel very dizzy and lightheaded when sitting. 10 min later re-assessed patient, continues to feel very dizzy and lightheaded when sitting. Medics arrived, EKG performed  and discovered very frequent multifocal PVCs  Pt was transported to ED for further evaluation.
Nodule, redness, swelling of left thigh. Mother treated with compresses and Tylenol for fever. Follow up on 11/06/2003: "Vaccine recipient did recover from the adverse event."
Information has been received from a physician concerning a male patient who was approximately five years old was vaccinated with MMR II a few months ago and had an anaphylactic reaction. The physician stated that they were not sure why the patient had a reaction. The physician told that they think possibly it is the gelatin component but they don't know for sure. The physician told that the patient was hospitalized and everything resolved back to normal with this patient after approximately one day of hospitalization. The physician also stated that the patient was also given at the time DTAP and Poliovirus vaccine and the patient has also had an anaphylactic reaction to VARIVAX (Merck) (MSD, WAES 0907USA01481) in the past (date unknown). Additional information has been requested.
This spontaneous report as received from a nurse practitioner refers to a patient of unknown age and gender. The patient received the first dose of GARDASIL on 05-APR-2013, the second dose of GARDASIL on 05-JUN-2013 and was in the office today, 31-JUL-2013, wanting to get a third dose of GARDASIL (dose, frequency, route and lot# not reported). No adverse effect reported. Additional information has been requested.
Red raised rash on L cheek, R side down to R buttock, on back. Pt afebrile at 97.7, pt c/o sore throat, mother states he has now "high fever," but states she never checked it with a thermometer. Medical director MD notified, recommended the mother give the child liquid Benadryl for children per directions on bottle and if no better in 1 hr. bring child to ER. On 6/3/03 mother stated after giving Benadryl, rash is gone today.
Patient was administered a Pfizer Covid-19 vaccine that was exposed to a temperature excursion. (Vaccine was between 8-14.5 degrees C for 7hrs and 48 minutes). Pfizer was contacted and advised the clinic to consider the dose as invalid and to revaccinate. Patient was revaccinated on 03/19/21 and has since recevied dose 2 on 04/09/21.
Nausea; Vomiting; Fever; Muscle pain; Fatigue; Swollen lymph nodes; Sore throat; This is spontaneous report from a contactable consumer. This consumer (patient) reported). A patient of unspecified age and gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID -19 VACCINE, solution for injection, Lot Number: not reported, Expiry date: unknown) via an unspecified route of administration, administered on 28Apr2021 as dose 1, single for COVID-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. On 13May2021, patient experienced nausea, vomiting, fever, muscle pain, fatigue, swollen lymph nodes, throat was just sore. The reporter stated, "I have like all the side effects and its been going on since Thursday of last week, like Thursday night its not getting better, not getting worse, just not getting any better." "I was taking like NyQuil and DayQuil, I try to break my fever with some Tylenol. I was also taking Theraflu. (Intent: Treatment)". The reporter also stated that I cannot understand you but nothing is worse, it makes me feel better and then I go back to feel like nothing in that 3 hours, like I have a fever." Nausea, Vomiting, fever, muscle pain, fatigue, swollen lymph nodes, my throat is just sore right now. I have like 7 problems in 7 days. I cannot break my fever with the Tylenol like I usually do, I do not get sick." The patient stated that, "I am supposed to go take it today but I am not sure if I should. I have my second dosage today and I do not know if I should go and take it." The patient confirmed, patient took Theraflu as a treatment for the side effects, stated, and also Tylenol, it (Tylenol) was supposed to break fever but it never worked. It didnt do anything." The side effects are coming through the vaccine that patient got. Patient cannot break fever with the Tylenol like usually do. Patient took the Theraflu because having the side effect from the Pfizer shot the Theraflu was the medicine that took, it was over the counter medication. The patient asked my second dosage today and I do not know if I should go and take it. The patient received treatment for the events. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Systemic: Pt developed symptoms approximately 20 minutes post-vaccination. Pt reported feeling a headache, numbness, and feeling hungry. Pt had elevated HR approximately 110 and O2 sat in high 90s. BP in 130s/8; symptoms lasted 0 days
Softball size raised area and blotchy. Redness on arm and neck. Area very hot and sore. Hurts to lift arm.
Fever of 103 for 12 hrs, 101-100 for next 12 hrs, severe shakes at times, strong muscle aches and body pain, general feeling of being very ill, and exhaustion over next 4 days.
Missing partial smell, no longer smell perfume; Missing partial taste, everything tastes different; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6208) via an unspecified route of administration in the left arm on 17Mar2021 at 14:00 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, neuromyelitis optica spectrum disorder (misdiagnosed NMOSD). The patient had known allergies to penicillin, keflex, ceclor, synthroid, gluten and latex. Concomitant medications included thyroid (ARMOUR THYROID) and amantadine (MANUFACTURER UNKNOWN) all from unknown dates for unknown medication and unknown if ongoing. eculizumab (SOLIRIS) for unknown indication, from unknown start date and since May2021 have stopped soliris. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6208) via an unspecified route of administration in the left arm on 24Feb2021 at 15:00 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Since the vaccination, the patient had been tested for COVID-19. The patient underwent lab tests and procedures, which included COVID-19 test (blood test) on 09Apr2021 and result was negative. On 21Jun2021 the patient experienced missing partial smell (she could no longer smell perfume) and taste (everything tasted different). The patient was training to be a sommelier. Loss of taste, smell did not start until june2021. The clinical outcome of the events missing partial smell (she could no longer smell perfume) and taste (everything tasted different) was not recovered at the time of this report.